KBI Biopharma is a biopharmaceutical contract services organization that offers fully-integrated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally. Their core services include mammalian and microbial cell line development, process development, analytical development, formulation development, characterization, clinical manufacturing, and commercial manufacturing. With a focus on accelerating drug development programs, KBI Biopharma provides efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. They are committed to driving breakthroughs in biopharmaceutical development to positively impact the lives of patients worldwide.